Amrize (NYSE:AMRZ) Reaches New 12-Month Low – Time to Sell?

Amrize Ltd (NYSE:AMRZGet Free Report)’s share price reached a new 52-week low on Tuesday . The stock traded as low as $39.42 and last traded at $39.4990, with a volume of 3738542 shares traded. The stock had previously closed at $40.52.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Wells Fargo & Company reissued an “equal weight” rating and set a $44.00 price objective (down from $55.00) on shares of Amrize in a research note on Wednesday, September 9th. Oppenheimer lowered their price target on Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a report on Tuesday, July 21st. Royal Bank Of Canada downgraded Amrize from a “sector perform” rating to an “underperform” rating and dropped their price target for the company from $60.00 to $48.00 in a research report on Monday, August 10th. Citigroup lowered Amrize from a “buy” rating to a “cautious” rating in a report on Wednesday, September 9th. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eight have assigned a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $55.50.

Read Our Latest Stock Analysis on AMRZ

Amrize Price Performance

The business’s fifty day moving average price is $46.48 and its 200-day moving average price is $51.92. The company has a market capitalization of $21.23 billion, a P/E ratio of 17.69, a P/E/G ratio of 1.17 and a beta of 0.04. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33.

Amrize (NYSE:AMRZGet Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The firm had revenue of $3.49 billion during the quarter. As a group, sell-side analysts predict that Amrize Ltd will post 2.67 earnings per share for the current fiscal year.

Amrize Announces Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize’s dividend payout ratio is 20.28%.

Insider Activity at Amrize

In other Amrize news, insider Stephen S. Clark purchased 5,260 shares of Amrize stock in a transaction on Tuesday, August 11th. The shares were acquired at an average cost of $47.31 per share, for a total transaction of $248,850.60. Following the completion of the transaction, the insider directly owned 10,637 shares of the company’s stock, valued at approximately $503,236.47. The trade was a 97.82% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Mario Gross purchased 3,568 shares of Amrize stock in a transaction on Tuesday, August 11th. The shares were acquired at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the transaction, the insider directly owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. The trade was a 10.22% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 48,983 shares of company stock worth $2,158,755 in the last quarter. 0.54% of the stock is owned by company insiders.

Institutional Investors Weigh In On Amrize

A number of institutional investors have recently made changes to their positions in the business. National Pension Service lifted its stake in Amrize by 7.5% in the second quarter. National Pension Service now owns 1,493,022 shares of the company’s stock worth $79,578,000 after purchasing an additional 103,962 shares during the last quarter. NewEdge Advisors LLC grew its stake in shares of Amrize by 1,419.7% during the second quarter. NewEdge Advisors LLC now owns 2,082 shares of the company’s stock valued at $111,000 after buying an additional 1,945 shares during the last quarter. Arizona State Retirement System grew its stake in shares of Amrize by 5.5% during the second quarter. Arizona State Retirement System now owns 142,718 shares of the company’s stock valued at $7,607,000 after buying an additional 7,440 shares during the last quarter. Murphy Pohlad Asset Management LLC increased its holdings in shares of Amrize by 2.5% in the second quarter. Murphy Pohlad Asset Management LLC now owns 61,005 shares of the company’s stock worth $3,252,000 after buying an additional 1,495 shares during the period. Finally, Saudi Central Bank increased its holdings in shares of Amrize by 89.6% in the second quarter. Saudi Central Bank now owns 34,844 shares of the company’s stock worth $1,857,000 after buying an additional 16,471 shares during the period.

Amrize Company Profile

(Get Free Report)

Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.

Recommended Stories

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.